SAN DIEGO, Jan. 29, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Leerink Global Healthcare Conference in New York, NY. The presentation will take place on Wednesday, February 12, 2014 at 11:05am Eastern Time (8:05am Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20131220/LA37333LOGO)
The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Investor Events" section.
About Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company manufactures and sells the t:slim Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the first and only insulin pump with a high resolution, color touch screen. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim and #tconnect. Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
t:slim, t:connect, and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.
SOURCE Tandem Diabetes Care, Inc.